TherapeuticsMD (TXMD) Short-term Investments (2022)
TherapeuticsMD (TXMD) posted Short-term Investments of $11.2 million for Q4 2022, little changed on a QoQ basis from $11.2 million in Q3 2022.
TherapeuticsMD (TXMD) Short-term Investments (2022) Analysis & Trends
TherapeuticsMD's Short-term Investments history runs 1 years deep, the most recent figure standing at $11.2 million for Q4 2022.
- Quarterly Short-term Investments changed N/A year-over-year to $11.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $11.2 million (changed N/A YoY) and the FY2022 annual result came in at $11.2 million, changed N/A from the prior year.
- Short-term Investments was $11.2 million for Q4 2022 at TherapeuticsMD, roughly flat from $11.2 million in the prior quarter.
- Across five years, Short-term Investments topped out at $11.2 million in Q2 2022 and bottomed at $11.2 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 11.25 Mn |
| Sep 30, 2022 | 11.25 Mn |
| Jun 30, 2022 | 11.25 Mn |